These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 16620701)
1. Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteases. Sun CY; Hu Y; Wang HF; He WJ; Wang YD; Wu T Chin Med J (Engl); 2006 Apr; 119(7):589-95. PubMed ID: 16620701 [TBL] [Abstract][Full Text] [Related]
2. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. Kim MH J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886 [TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2. Ottino P; Taheri F; Bazan HE Exp Eye Res; 2002 Mar; 74(3):393-402. PubMed ID: 12014920 [TBL] [Abstract][Full Text] [Related]
4. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum. Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571 [TBL] [Abstract][Full Text] [Related]
5. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells. Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of extracellular matrix components in the bovine oviduct during the oestrous cycle. Gabler C; Killian GJ; Einspanier R Reproduction; 2001 Jul; 122(1):121-30. PubMed ID: 11425336 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Schmalfeldt B; Prechtel D; Härting K; Späthe K; Rutke S; Konik E; Fridman R; Berger U; Schmitt M; Kuhn W; Lengyel E Clin Cancer Res; 2001 Aug; 7(8):2396-404. PubMed ID: 11489818 [TBL] [Abstract][Full Text] [Related]
8. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells. Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475 [TBL] [Abstract][Full Text] [Related]
9. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. Ottino P; He J; Axelrad TW; Bazan HE Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273 [TBL] [Abstract][Full Text] [Related]
10. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression. Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672 [TBL] [Abstract][Full Text] [Related]
11. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition. Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427 [TBL] [Abstract][Full Text] [Related]
12. Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1beta and tumor necrosis factor-alpha. Meller D; Li DQ; Tseng SC Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2922-9. PubMed ID: 10967046 [TBL] [Abstract][Full Text] [Related]
13. The plasminogen-activating system in hepatic stellate cells. Leyland H; Gentry J; Arthur MJ; Benyon RC Hepatology; 1996 Nov; 24(5):1172-8. PubMed ID: 8903394 [TBL] [Abstract][Full Text] [Related]
14. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential. Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts. Li DQ; Meller D; Liu Y; Tseng SC Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):404-10. PubMed ID: 10670469 [TBL] [Abstract][Full Text] [Related]
16. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells. Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618 [TBL] [Abstract][Full Text] [Related]
17. Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines. Solomon A; Li DQ; Lee SB; Tseng SC Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2154-63. PubMed ID: 10892857 [TBL] [Abstract][Full Text] [Related]
18. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471 [TBL] [Abstract][Full Text] [Related]
19. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation. Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407 [TBL] [Abstract][Full Text] [Related]
20. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia. Tai SH; Chen HY; Lee EJ; Chen TY; Lin HW; Hung YC; Huang SY; Chen YH; Lee WT; Wu TS J Pineal Res; 2010 Nov; 49(4):332-41. PubMed ID: 20663046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]